跳至主要内容
临床试验/NCT04273594
NCT04273594进行中(未招募)不适用

BLOC: Prospective, Multi-Center, Study of Subjects Undergoing FemBloc Permanent Contraception With Two Confirmation Procedures (FemBloc With FemChec and Fluoro HSG)

Femasys Inc.12 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2020年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Femasys Inc.
入组人数
45
试验地点
12
主要终点
Concordance

研究概览

简要总结

The trial objectives include evaluating the adequacy of proposed mitigations for the previous pivotal trial of the FemBloc Permanent Contraceptive System and validating the confirmation procedure by comparing FemChec (ultrasound) to fluoroscopic hysterosalpingogram (fluoro HSG) for post-occlusion in the same patient.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female, 21 - 45 years of age desiring permanent birth control
  • Sexually active with male partner
  • Regular menstrual cycle for last 3 months or on hormonal contraceptives

排除标准

  • Uncertainty about the desire to end fertility
  • Known or suspected pregnancy
  • Prior tubal surgery, including sterilization attempt
  • Prior endometrial ablation
  • Presence, suspicion, or previous history of gynecologic malignancy
  • Abnormal uterine bleeding requiring evaluation or treatment
  • Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
  • Allergy to shellfish, betadine or iodinated contrast

结局指标

主要结局

Concordance

时间窗: within 1 year

Concordance between FemBloc confirmation with FemChec and Fluoro HSG confirmation

Reliance Rate

时间窗: within 1 year

Number of subjects told to rely divided by number of qualified subjects

次要结局

未报告次要终点

研究者

发起方
Femasys Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验